
HF 753 (see companion bill SF 272) – Minnesota
Status: Inactive / DeadYear Introduced: 2019
Link: https://www.revisor.mn.gov/bills/bill.php?b=House&f=HF0753&ssn=0&y=2019
Price gouging by manufacturer or wholesale drug distributor prohibited; Board of Pharmacy, commissioner of human services, and health plan companies allowed to notify the attorney general of prescription drug price increases; attorney general authorized to obtain drug pricing information and take action against manufacturers and wholesalers for price increases; and civil penalties imposed.
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found